Eli Lilly and Co (LTS:0Q1G) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0Q1G Eli Lilly and Co LTS:0Q1G
87 GF Score
Price CHF1,020.00
GF Value CHF882.28
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Eli Lilly and Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0Q1G vs JNJ, ABBV, MRK: Short Percentage of Float Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eli Lilly and Co Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Short Percentage of Float falls into.


LTS:0Q1G
87GF Score
Eli Lilly and Co LTS:0Q1G
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (LTS:0Q1G) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be overvalued. The current stock price of CHF1,020.00 is trading 15.6% above its estimated GF Value™ of CHF882.28. GuruFocus considers Eli Lilly and Co to be Modestly Overvalued.

Key valuation signals for LTS:0Q1G:

  • Short Percentage of Float:
  • GF Value™: CHF882.28 vs. price of CHF1,020.00 (15.6% above fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the LTS:0Q1G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
87GF Score

Get the complete analysis for LTS:0Q1G

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1,020.00
Price
CHF882.28
GF Value